Home  >  Seminars  >  Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging
Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging
By Frédéric Ducongé (CEA, I2BM, SHFJ - INSERM U1023).
May 27, 2013 at 11:00AM - Salle de réunion du LJP

Abstract

Frédéric Ducongé will give a talk on "Aptameres screening and nanoparticules that can target tumors via in vivo optival imaging".